Melioidosis: Epidemiology, Pathophysiology, and Management
By A. Cheng, Bart J. Currie. Clinical Microbiology Reviews, 2005
1,508 citations recorded by the source corpus.
Subfields: Epidemiology
View Paper: https://www.semanticscholar.org/paper/f427c9203c416bc32684277c6df1cbfaa6d692f0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei (2006, background): “pseudomallei is intrinsically resistant to many antibiotics (including penicillin, first- and second-generation cephalosporins, macrolides, rifamycins, colistin and aminoglycosides), but is usually susceptible to amoxicillin-clavulanate, chloramphenicol, doxycycline, trimethoprim-sulphamethoxazole,”
- The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study (2010, background): “The dramatic presentation of melioidosis brainstem encephalitis or myelitis has been noted to be more commonly seen in Australia than in Thailand [1,3].”